Related Articles
Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression
Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9
PCSK9 as a therapeutic target for cardiovascular disease (Review)
Hepatic HNF1 transcription factors control the induction of PCSK9 mediated by rosuvastatin in normolipidemic hamsters
Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells